These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9266528)

  • 1. Q10 therapy in patients with idiopathic Parkinson's disease.
    Strijks E; Kremer HP; Horstink MW
    Mol Aspects Med; 1997; 18 Suppl():S237-40. PubMed ID: 9266528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring the effects of therapy in Parkinson disease.
    Shults CW; Haas R; Oakes D; Kieburtz K; Plumb S; Shoulson I; Beal MF; Juncos J; Nutt J
    JAMA; 2004 May; 291(20):2430-1; author reply 2431. PubMed ID: 15161889
    [No Abstract]   [Full Text] [Related]  

  • 3. Coenzyme Q10 for Parkinson's disease.
    Liu J; Wang L; Zhan SY; Xia Y
    Cochrane Database Syst Rev; 2011 Dec; (12):CD008150. PubMed ID: 22161420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ALS lessons learned from other neurological diseases. Parkinson's disease.
    Fahn S
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():26-30. PubMed ID: 15512865
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of coenzyme Q10 therapy in Parkinson disease could be symptomatic.
    Horstink MW; van Engelen BG
    Arch Neurol; 2003 Aug; 60(8):1170-2; author reply 1172-3. PubMed ID: 12925381
    [No Abstract]   [Full Text] [Related]  

  • 6. Neuroprotective actions of coenzyme Q10 in Parkinson's disease.
    Sharma S; Kheradpezhou M; Shavali S; El Refaey H; Eken J; Hagen C; Ebadi M
    Methods Enzymol; 2004; 382():488-509. PubMed ID: 15047119
    [No Abstract]   [Full Text] [Related]  

  • 7. Complex-1 activity and 18F-DOPA uptake in genetically engineered mouse model of Parkinson's disease and the neuroprotective role of coenzyme Q10.
    Sharma SK; El Refaey H; Ebadi M
    Brain Res Bull; 2006 Jun; 70(1):22-32. PubMed ID: 16750479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial dysfunction and oxidative damage in Alzheimer's and Parkinson's diseases and coenzyme Q10 as a potential treatment.
    Beal MF
    J Bioenerg Biomembr; 2004 Aug; 36(4):381-6. PubMed ID: 15377876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coenzyme Q10: a review of its promise as a neuroprotectant.
    Young AJ; Johnson S; Steffens DC; Doraiswamy PM
    CNS Spectr; 2007 Jan; 12(1):62-8. PubMed ID: 17192765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coenzyme Q10 in early Parkinson disease.
    Hunter DA
    Arch Neurol; 2003 Aug; 60(8):1170; author reply 1172-3. PubMed ID: 12925382
    [No Abstract]   [Full Text] [Related]  

  • 11. Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's disease.
    Shults CW; Flint Beal M; Song D; Fontaine D
    Exp Neurol; 2004 Aug; 188(2):491-4. PubMed ID: 15246848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coenzyme Q10 for Patients with Parkinson's Disease: A Systematic Review and Meta-Analysis.
    Negida A; Menshawy A; El Ashal G; Elfouly Y; Hani Y; Hegazy Y; El Ghonimy S; Fouda S; Rashad Y
    CNS Neurol Disord Drug Targets; 2016; 15(1):45-53. PubMed ID: 26553164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of belief in neuroprotection on therapeutic intervention in Parkinson's disease.
    Elble RJ; Suchowersky O; Shaftman S; Weiner WJ; Huang P; Tilley B;
    Mov Disord; 2010 Jun; 25(8):1082-6. PubMed ID: 20131372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotection in Parkinson disease: mysteries, myths, and misconceptions.
    Schapira AH; Olanow CW
    JAMA; 2004 Jan; 291(3):358-64. PubMed ID: 14734599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coenzyme Q10.
    Med Lett Drugs Ther; 2006 Feb; 48(1229):19-20. PubMed ID: 16498307
    [No Abstract]   [Full Text] [Related]  

  • 16. Randomized, double-blind, placebo-controlled pilot trial of reduced coenzyme Q10 for Parkinson's disease.
    Yoritaka A; Kawajiri S; Yamamoto Y; Nakahara T; Ando M; Hashimoto K; Nagase M; Saito Y; Hattori N
    Parkinsonism Relat Disord; 2015 Aug; 21(8):911-6. PubMed ID: 26054881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Coenzyme Q10 in Huntington's disease and early Parkinson's disease.
    Beal MF; Shults CW
    Biofactors; 2003; 18(1-4):153-61. PubMed ID: 14695931
    [No Abstract]   [Full Text] [Related]  

  • 18. Coenzyme Q10 supplementation provides mild symptomatic benefit in patients with Parkinson's disease.
    Müller T; Büttner T; Gholipour AF; Kuhn W
    Neurosci Lett; 2003 May; 341(3):201-4. PubMed ID: 12697283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A possible role of coenzyme Q10 in the etiology and treatment of Parkinson's disease.
    Shults CW; Haas RH; Beal MF
    Biofactors; 1999; 9(2-4):267-72. PubMed ID: 10416040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Differential therapy of advanced Parkinson's disease with special reference to complementary therapeutic approaches].
    Ulm G
    Praxis (Bern 1994); 2004 Nov; 93(45):1869-72. PubMed ID: 15571302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.